The dissection of molecular pathways targeted by the FKBP19 protein, and the analysis of FKBP11 expression in larger cohorts of patients, looking for correlation between FKBP11 levels in B cells and clinical phenotypes of SLE patients, may lead to the identification of new molecular targets in SLE. This evidence concerns the gene FKBP11 and systemic lupus erythematosus.